Eastern Cooperative Oncology Group
- Country
- 🇺🇸United States
- Ownership
- Private, Subsidiary
- Established
- 2012-01-01
- Employees
- 51
- Market Cap
- -
- Website
- https://ecog-acrin.org
Marimastat or No Further Therapy in Treating Women With Metastatic Breast Cancer That Is Responding or Stable Following Chemotherapy
- Conditions
- Breast Cancer
- First Posted Date
- 2004-04-14
- Last Posted Date
- 2023-06-15
- Lead Sponsor
- Eastern Cooperative Oncology Group
- Target Recruit Count
- 334
- Registration Number
- NCT00003010
- Locations
- 🇺🇸
CCOP - Carle Cancer Center, Urbana, Illinois, United States
🇺🇸Siouxland Hematology-Oncology, Sioux City, Iowa, United States
🇺🇸CCOP - Duluth, Duluth, Minnesota, United States
Fluorouracil-Uracil and Leucovorin in Treating Elderly Patients With Metastatic Colorectal Cancer
- Conditions
- Colorectal Cancer
- First Posted Date
- 2004-04-12
- Last Posted Date
- 2023-06-15
- Lead Sponsor
- Eastern Cooperative Oncology Group
- Registration Number
- NCT00004860
- Locations
- 🇺🇸
University of Pittsburgh Cancer Institute, Pittsburgh, Pennsylvania, United States
🇺🇸Johns Hopkins Oncology Center, Baltimore, Maryland, United States
🇺🇸Fox Chase Cancer Center, Philadelphia, Pennsylvania, United States
Two-Drug Combination Chemotherapy Compared With Four-Drug Combination Chemotherapy in Treating Patients With Advanced Cancer of the Urothelium
- Conditions
- Transitional Cell Cancer of the Renal Pelvis and UreterUrethral CancerBladder Cancer
- First Posted Date
- 2004-04-09
- Last Posted Date
- 2023-06-22
- Lead Sponsor
- Eastern Cooperative Oncology Group
- Target Recruit Count
- 330
- Registration Number
- NCT00003376
- Locations
- 🇺🇸
University of Illinois at Chicago Health Sciences Center, Chicago, Illinois, United States
🇺🇸Veterans Affairs Medical Center - Chicago (Westside Hospital), Chicago, Illinois, United States
🇺🇸University of Chicago Cancer Research Center, Chicago, Illinois, United States
Temozolomide and Radiation Therapy in Treating Patients With Brain Metastasis Secondary to Non-Small Cell Lung Cancer
- Conditions
- Metastatic CancerLung Cancer
- Interventions
- Radiation: Radiation therapy
- First Posted Date
- 2004-04-08
- Last Posted Date
- 2023-06-29
- Lead Sponsor
- Eastern Cooperative Oncology Group
- Target Recruit Count
- 26
- Registration Number
- NCT00080938
Cryosurgery in Treating Patients With Unresectable Liver Metastases From Colorectal Cancer
- Conditions
- Metastatic CancerColorectal Cancer
- First Posted Date
- 2004-04-07
- Last Posted Date
- 2023-06-15
- Lead Sponsor
- Eastern Cooperative Oncology Group
- Registration Number
- NCT00002997
- Locations
- 🇺🇸
Hahnemann University Hospital, Philadelphia, Pennsylvania, United States
🇺🇸University of Rochester Cancer Center, Rochester, New York, United States
🇺🇸Hackensack University Medical Center, Hackensack, New Jersey, United States
Docetaxel Plus Carboplatin in Treating Patients With Advanced Cancer of the Esophagus
- Conditions
- Esophageal Cancer
- First Posted Date
- 2004-04-02
- Last Posted Date
- 2023-06-15
- Lead Sponsor
- Eastern Cooperative Oncology Group
- Registration Number
- NCT00003864
- Locations
- 🇺🇸
Emory University Hospital - Atlanta, Atlanta, Georgia, United States
🇺🇸Hahnemann University Hospital, Philadelphia, Pennsylvania, United States
🇺🇸University of Pennsylvania Cancer Center, Philadelphia, Pennsylvania, United States
Interleukin-12 in Treating Patients With Multiple Myeloma
- Conditions
- Multiple Myeloma and Plasma Cell Neoplasm
- First Posted Date
- 2004-03-30
- Last Posted Date
- 2013-06-21
- Lead Sponsor
- Eastern Cooperative Oncology Group
- Target Recruit Count
- 40
- Registration Number
- NCT00003149
- Locations
- 🇺🇸
CCOP - Ochsner, New Orleans, Louisiana, United States
🇺🇸Mayo Clinic Cancer Center, Rochester, Minnesota, United States
🇺🇸Overlook Hospital, Summit, New Jersey, United States
High-Dose Folic Acid in Preventing Colorectal Cancer in Patients Who Have Had Polyps Surgically Removed
- Conditions
- Colorectal Cancer
- First Posted Date
- 2004-03-11
- Last Posted Date
- 2023-06-22
- Lead Sponsor
- Eastern Cooperative Oncology Group
- Target Recruit Count
- 80
- Registration Number
- NCT00002650
- Locations
- 🇺🇸
Veterans Affairs Medical Center - Lakeside Chicago, Chicago, Illinois, United States
🇺🇸New England Medical Center Hospital, Boston, Massachusetts, United States
🇺🇸Robert H. Lurie Comprehensive Cancer Center, Northwestern University, Chicago, Illinois, United States
Docetaxel and Gemcitabine in Treating Patients With Progressive Regional or Metastatic Bladder Cancer
- Conditions
- Bladder CancerUrethral CancerTransitional Cell Cancer of the Renal Pelvis and Ureter
- First Posted Date
- 2004-02-25
- Last Posted Date
- 2023-06-18
- Lead Sponsor
- Eastern Cooperative Oncology Group
- Registration Number
- NCT00004223
- Locations
- 🇺🇸
Robert H. Lurie Comprehensive Cancer Center, Northwestern University, Chicago, Illinois, United States
🇺🇸Veterans Affairs Medical Center - Palo Alto, Palo Alto, California, United States
🇺🇸Veterans Affairs Medical Center - Lakeside Chicago, Chicago, Illinois, United States
Denileukin Diftitox in Treating Patients With Non-Hodgkin's Lymphoma
- Conditions
- Lymphoma
- First Posted Date
- 2004-02-20
- Last Posted Date
- 2023-06-15
- Lead Sponsor
- Eastern Cooperative Oncology Group
- Target Recruit Count
- 77
- Registration Number
- NCT00003615
- Locations
- 🇺🇸
Robert H. Lurie Comprehensive Cancer Center, Northwestern University, Chicago, Illinois, United States
🇺🇸CCOP - Geisinger Clinic and Medical Center, Danville, Pennsylvania, United States
🇺🇸Beth Israel Deaconess Medical Center, Boston, Massachusetts, United States